Astrana Health (ASTH) Stock Price, News & Analysis

Company Overview

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Key Stats

• Today's Range: $27.26 to $27.87
• 50-Day Range: $21.46 to $31.96
• 52-Week Range: $21.20 to $63.20
• Volume: 254,405 shs
• Average Volume: 342,594 shs
• Market Capitalization: $1.55 billion
• P/E Ratio: 54.20
• Dividend Yield: N/A
• Price Target: $53.29
• Consensus Rating: Moderate Buy

Astrana Health Stock Analysis - MarketRank™

Astrana Health scored higher than 84% of companies evaluated by MarketBeat, and ranked 202nd out of 946 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

Astrana Health has a consensus price target of $53.29, representing about 92.8% upside from its current price of $27.64.

Amount of Analyst Coverage

Astrana Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 22.61%

Earnings Growth

Earnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Astrana Health is 54.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.25.

Price to Earnings Ratio vs. Sector

The P/E ratio of Astrana Health is 54.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.42.

Price to Earnings Growth Ratio

Astrana Health has a PEG Ratio of 0.69. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Astrana Health has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.15% of the float of Astrana Health has been sold short.

Short Interest Ratio / Days to Cover

Astrana Health has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Astrana Health has recently decreased by 7.23%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Astrana Health does not currently pay a dividend.

Dividend Growth

Astrana Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.15% of the float of Astrana Health has been sold short.

Short Interest Ratio / Days to Cover

Astrana Health has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Astrana Health has recently decreased by 7.23%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Astrana Health has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.

Search Interest

8 people have searched for ASTH on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Astrana Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.46% of the stock of Astrana Health is held by insiders.

Percentage Held by Institutions

52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ASTH Stock Analysis - Frequently Asked Questions

How have ASTH shares performed this year?

Astrana Health's stock was trading at $31.53 at the beginning of 2025. Since then, ASTH stock has decreased by 12.3% and is now trading at $27.64.

How were Astrana Health's earnings last quarter?

Astrana Health, Inc. (NASDAQ:ASTH) announced its quarterly earnings data on Thursday, August, 7th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.36 by $0.17. Astrana Health's quarterly revenue was up 34.7% on a year-over-year basis.
Read the conference call transcript.

Who are Astrana Health's major shareholders?

Top institutional shareholders of Astrana Health include Geode Capital Management LLC (1.88%), SteelPeak Wealth LLC (0.96%), Bank of New York Mellon Corp (0.45%) and Invesco Ltd. (0.43%).

How do I buy shares of Astrana Health?

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Astrana Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/23/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:ASTH
• Previous Symbol: NASDAQ:ASTH
• CIK: 1083446
• Web: www.apollomed.net
• Phone: 626-282-0288
• Fax: 818-839-5190
• Employees: 1,900
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Astrana Health: $53.29
• High Price Target: $70.00
• Low Price Target: $36.00
• Potential Upside/Downside: +92.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.51
• Trailing P/E Ratio: 54.20
• Forward P/E Ratio: 24.03
• P/E Growth: 0.69
• Net Income: $43.15 million
• Net Margins: 1.04%
• Pretax Margin: 2.12%
• Return on Equity: 3.43%
• Return on Assets: 1.87%

Debt

• Debt-to-Equity Ratio: 0.52
• Current Ratio: 1.59
• Quick Ratio: 1.59

Sales & Book Value

• Annual Sales: $2.03 billion
• Price / Sales: 0.76
• Cash Flow: $1.48 per share
• Price / Cash Flow: 18.71
• Book Value: $14.59 per share
• Price / Book: 1.89

Miscellaneous

• Outstanding Shares: 56,060,000
• Free Float: 51,317,000
• Market Cap: $1.55 billion
• Optionable: Optionable
• Beta: 0.84